Track this trial free. DataLookout checks ClinicalTrials.gov daily and emails you which fields changed on NCT04760860 (status, enrollment, completion dates, endpoints, sites) when this record is updated. Free accounts track up to 5 trials.

Track this trial

Terazosin for Dementia With Lewy Bodies

Study acronym: TZ-DLB
StatusNot Yet Recruiting
PhasePhase 1/2
Started2027-10
View on ClinicalTrials.gov ↗
The TZ-DLB trial will be a 3:2 (active:placebo) randomized, double-blind, placebo-controlled Pilot trial to evaluate the tolerability of terazosin for the treatment of dementia with Lewy bodies.

Amendment record

Amended 5 times since 2021-02-15; most recent filed 2026-03-10. Every amendment is listed below.

Dates here are the day the sponsor filed the amendment, not the day ClinicalTrials.gov published it. Version history last read from ClinicalTrials.gov on 2026-08-30.

2026-03-10
Amendment Study Status v5
2025-02-06
Amendment Study Status v4
2024-05-09
Amendment Study Status v3
2023-05-04
Amendment Study Status v2
2021-02-26
Amendment Study Identification, Study Status, Study Description, Study Design, Arms and Interventions, Outcome Measures, Eligibility v1
2021-02-15
Original filing
Trial Details
NCT Number NCT04760860
Lead Sponsor Qiang Zhang
Conditions Dementia With Lewy Bodies
Enrollment 40 participants
Start Date 2027-10
Primary Completion 2030-10 (estimated)
Study Completion 2030-12 (estimated)
Updated on ClinicalTrials.gov 2026-03-12